Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment.
The objectives of this study were to assess the costs of psoriatic arthritis (PsA) in Hungary and to identify key cost drivers among demographic and clinical variables and to compare cost-of-illness of PsA and rheumatoid arthritis (RA). Cross-sectional retrospective survey of 183 consecutive patients from eight rheumatology centres was conducted. Mean direct medical, direct non medical, indirect and total costs were 1,876, 794, 2,904 and 5,574 euros/patient/year, respectively. Total costs were in significant linear relationship with health assessment questionnaire score and psoriatic area severity index. Costs of RA were higher in all domains than of PsA. Our study was the first from the Eastern European region that provides cost-of-illness data on PsA. Our study revealed that functional status and severity of skin symptoms were the key cost drivers. The costs of PsA in Hungary were lower than in the high-income European countries.
Brodszky
Valentin
V
Health Economics and Technology Assessment Research Centre, Corvinus University of Budapest, Fővám tér 8, 1093 Budapest, Hungary. valentin.brodszky@uni-corvinus.hu
Bálint
Péter
P
Géher
Pál
P
Hodinka
László
L
Horváth
Gábor
G
Koó
Éva
É
Péntek
Márta
M
Polgár
Anna
A
Seszták
Magdolna
M
Szántó
Sándor
S
Ujfalussy
Ilona
I
Gulácsi
László
L
D000368:Aged; D015535:Arthritis, Psoriatic / Q000191:economics*; D001172:Arthritis, Rheumatoid / Q000191:economics*; D017281:Cost of Illness; D003430:Cross-Sectional Studies; D004185:Disability Evaluation; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D012189:Retrospective Studies; D012720:Severity of Illness Index